Bellevue Group AG
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
154 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.7% | $4,190,162,648 |
| Energy | 0.1% | $2,947,754 |
| Technology | 0.1% | $2,547,209 |
| Unclassified | 0.0% | $1,755,918 |
| Financial Services | 0.0% | $1,405,531 |
| Consumer Cyclical | 0.0% | $1,196,721 |
| Consumer Defensive | 0.0% | $563,316 |
| Communication Services | 0.0% | $90,293 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | +3,275,960 | 3,280,000 | $119,129,600 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +2,377,420 | 2,380,000 | $49,861,000 | |
| VRDN | Viridian Therapeutics, Inc.\DE | +2,367,617 | 6,726,144 | $131,563,376 | |
| GILD | Gilead Sciences, Inc. | +1,117,127 | 1,169,879 | $163,046,036 | |
| AMGN | Amgen Inc | +276,869 | 295,358 | $103,921,712 | |
| REGN | Regeneron Pharmaceuticals, Inc. | +264,746 | 278,674 | $215,314,678 | |
| MDT | Medtronic plc | +190,737 | 957,329 | $82,952,557 | |
| JBIO | Jade Biosciences, Inc. | +160,399 | 3,501,502 | $49,196,103 | |
| MRK | Merck & Co., Inc. | +114,474 | 206,591 | $24,850,831 | |
| KRYS | Krystal Biotech, Inc. | +71,462 | 481,785 | $124,454,701 | |
| PFE | Pfizer Inc | +50,788 | 107,635 | $3,022,390 | |
| RPRX | Royalty Pharma plc | +25,095 | 38,296 | $1,837,059 | |
| MDLN | Medline Inc. | +18,915 | 136,635 | $6,080,257 | |
| NUVL | Nuvalent, Inc. | +15,800 | 1,053,268 | $107,907,306 | |
| WAY | Waystar Holding Corp. | +14,405 | 256,139 | $6,175,511 | |
| VERA | Vera Therapeutics, Inc. | +12,619 | 1,710,771 | $68,824,316 | |
| OLMA | Olema Pharmaceuticals, Inc. | +12,541 | 16,443 | $245,165 | |
| DNLI | Denali Therapeutics Inc. | +10,628 | 17,766 | $341,107 | |
| MLYS | Mineralys Therapeutics, Inc. | +9,548 | 29,374 | $795,741 | |
| DHR | Danaher Corp /De/ | +7,531 | 202,164 | $38,330,294 | |
| TXG | 10x Genomics, Inc. | +7,432 | 329,492 | $6,995,115 | |
| TVTX | Travere Therapeutics, Inc. | +5,072 | 8,899 | $264,389 | |
| TMDX | TransMedics Group, Inc. | +3,254 | 101,139 | $10,054,227 | |
| CRSP | CRISPR Therapeutics AG | +3,136 | 5,016 | $238,611 | |
| ALKS | Alkermes plc. | +2,276 | 8,870 | $313,643 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | −3,461,263 | 1,544,456 | $150,198,346 | |
| IONS | Ionis Pharmaceuticals Inc | −2,983,534 | 1,818,665 | $136,563,554 | |
| CLDX | Celldex Therapeutics, Inc. | −2,417,669 | 1,200,000 | $38,064,000 | |
| NBIX | Neurocrine Biosciences Inc | −1,698,658 | 4,646 | $612,064 | |
| TNGX | Tango Therapeutics, Inc. | −1,527,670 | 2,400,000 | $50,208,000 | |
| WVE | Wave Life Sciences Ltd. | −1,485,257 | 5,261 | $38,142 | |
| RLAY | Relay Therapeutics, Inc. | −550,122 | 7,795,242 | $77,562,657 | |
| SRRK | Scholar Rock Holding Corp | −472,019 | 3,584,573 | $176,217,608 | |
| ADPT | Adaptive Biotechnologies Corp | −221,909 | 76,181 | $264,348 | |
| PRVA | Privia Health Group, Inc. | −221,460 | 226,703 | $4,663,280 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | −211,360 | 234,543 | $77,603,241 | |
| EW | Edwards Lifesciences Corp | −203,645 | 839,451 | $67,223,236 | |
| ABT | Abbott Laboratories | −165,280 | 1,151,635 | $118,238,365 | |
| ARGX | Argenx SE | −148,854 | 313,000 | $228,568,250 | |
| BDX | Becton Dickinson & Co | −143,775 | 121,887 | $19,164,293 | |
| SYK | Stryker Corp | −143,340 | 217,237 | $71,381,905 | |
| GPCR | Structure Therapeutics Inc. | −138,364 | 6,803 | $327,904 | |
| PEN | Penumbra Inc | −123,128 | 12,267 | $4,028,114 | |
| GKOS | GLAUKOS Corp | −116,232 | 145,703 | $15,686,384 | |
| BSX | Boston Scientific Corp | −92,712 | 1,466,894 | $92,047,598 | |
| MASI | Masimo Corp | −88,532 | 8,753 | $1,556,896 | |
| ZBH | Zimmer Biomet Holdings, Inc. | −83,109 | 155,571 | $14,066,729 | |
| TEVA | Teva Pharmaceutical Industries Ltd | −77,781 | 250,082 | $7,532,469 | |
| DXCM | Dexcom Inc | −58,639 | 788,766 | $49,534,504 | |
| PHR | Phreesia, Inc. | −52,221 | 130,992 | $1,097,712 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | 2,320,867 | $90,977,986 | |
| PCVX | Vaxcyte, Inc. | 1,190,697 | $69,191,402 | |
| DMRA | Damora Therapeutics, Inc. | 2,298,000 | $59,518,200 | |
| IRON | Disc Medicine, Inc. | 459,314 | $29,368,537 | |
| ORKA | Oruka Therapeutics, Inc. | 507,008 | $24,868,742 | |
| GLUE | Monte Rosa Therapeutics, Inc. | 1,250,000 | $20,562,500 | |
| LIVN | LivaNova PLC | 186,185 | $11,833,918 | |
| RNA | Atrium Therapeutics, Inc. | 263,096 | $3,517,593 | |
| EQNR | Equinor ASA | 17,573 | $741,580 | |
| XOM | ExxonMobil Holdings Corp | 4,370 | $741,414 | |
| BP | Bp PLC | 15,644 | $735,268 | |
| SHEL | Shell plc | 7,844 | $729,492 | |
| PRAX | Praxis Precision Medicines, Inc. | 1,757 | $566,087 | |
| AGMB | Agomab Therapeutics NV | 50,000 | $524,500 | |
| CNTA | Centessa Pharmaceuticals plc | 9,030 | $358,671 | |
| HALO | Halozyme Therapeutics, Inc. | 3,857 | $249,277 | |
| ABVX | Abivax S.A. | 1,048 | $116,694 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 6,982 | $62,488 | |
| QGEN | Qiagen N.V. | 243 | $9,729 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS, INC. | 10,735,195 | $152,869,176 | |
| MAZE | Maze Therapeutics, Inc. | 887,708 | $36,777,742 | |
| CDNA | CareDx, Inc. | 431,070 | $8,121,358 | |
| MOH | Molina Healthcare, Inc. | 46,626 | $8,091,476 | |
| ICLR | Icon PLC | 24,560 | $4,475,323 | |
| BMRN | Biomarin Pharmaceutical Inc | 65,008 | $3,863,424 | |
| BTSG | BrightSpring Health Services, Inc. | 92,095 | $3,448,957 | |
| NEO | Neogenomics Inc | 278,286 | $3,272,643 | |
| AVTR | Avantor, Inc. | 276,266 | $3,166,008 | |
| BEAM | Beam Therapeutics Inc. | 111,510 | $3,091,056 | |
| VKTX | Viking Therapeutics, Inc. | 68,665 | $2,415,634 | |
| ROIV | Roivant Sciences Ltd. | 108,039 | $2,344,446 | |
| BKD | Brookdale Senior Living Inc. | 167,444 | $1,806,720 | |
| SIBN | SI-BONE, Inc. | 90,331 | $1,781,327 | |
| EXAS | EXACT SCIENCES CORP | 16,062 | $1,631,256 | |
| CMPS | COMPASS Pathways plc | 142,243 | $981,476 | |
| ANET | Arista Networks, Inc. | 4,800 | $628,944 | |
| META | Meta Platforms, Inc. | 800 | $528,072 | |
| DOCS | Doximity, Inc. | 11,817 | $523,256 | |
| LULU | lululemon athletica inc. | 2,240 | $465,494 | |
| PLTR | Palantir Technologies Inc. | 2,500 | $444,375 | |
| CORT | Corcept Therapeutics Inc | 10,495 | $365,226 | |
| PLNT | Planet Fitness, Inc. | 3,173 | $344,175 | |
| EXEL | Exelixis, Inc. | 7,361 | $322,632 | |
| GH | Guardant Health, Inc. | 3,004 | $306,828 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Added | 681,908 | $304,499,197 | 7.25% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 313,000 | $228,568,250 | 5.44% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Added | 278,674 | $215,314,678 | 5.13% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 3,584,573 | $176,217,608 | 4.19% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Added | 1,169,879 | $163,046,036 | 3.88% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 1,544,456 | $150,198,346 | 3.58% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 1,818,665 | $136,563,554 | 3.25% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 286,654 | $132,144,627 | 3.15% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 6,726,144 | $131,563,376 | 3.13% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Added | 481,785 | $124,454,701 | 2.96% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 3,280,000 | $119,129,600 | 2.84% | |
| ABT |
Abbott Laboratories
Healthcare
|
Reduced | 1,151,635 | $118,238,365 | 2.81% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 1,053,268 | $107,907,306 | 2.57% | |
| AMGN |
Amgen Inc
Healthcare
|
Added | 295,358 | $103,921,712 | 2.47% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 1,466,894 | $92,047,598 | 2.19% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 2,320,867 | $90,977,986 | 2.17% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Held | 2,796,803 | $84,323,610 | 2.01% | |
| MDT |
Medtronic plc
Healthcare
|
Added | 957,329 | $82,952,557 | 1.97% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 234,543 | $77,603,241 | 1.85% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Reduced | 7,795,242 | $77,562,657 | 1.85% | |
| SYK |
Stryker Corp
Healthcare
|
Reduced | 217,237 | $71,381,905 | 1.70% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
NEW | 1,190,697 | $69,191,402 | 1.65% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 1,710,771 | $68,824,316 | 1.64% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 839,451 | $67,223,236 | 1.60% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 2,298,000 | $59,518,200 | 1.42% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 2,400,000 | $50,208,000 | 1.20% | |
| IDXX |
Idexx Laboratories Inc /De
Healthcare
|
Reduced | 89,131 | $50,081,817 | 1.19% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 2,380,000 | $49,861,000 | 1.19% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 788,766 | $49,534,504 | 1.18% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Added | 3,501,502 | $49,196,103 | 1.17% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 1,528,518 | $48,148,317 | 1.15% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Reduced | 148,203 | $40,102,249 | 0.95% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Added | 202,164 | $38,330,294 | 0.91% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 1,200,000 | $38,064,000 | 0.91% | |
| RMD |
Resmed Inc
Healthcare
|
Reduced | 159,346 | $35,769,990 | 0.85% | |
| PODD |
Insulet Corp
Healthcare
|
Reduced | 163,656 | $34,341,575 | 0.82% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Reduced | 64,412 | $31,660,430 | 0.75% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 33,932 | $31,209,635 | 0.74% | |
| GEHC |
GE HealthCare Technologies Inc.
Healthcare
|
Reduced | 416,887 | $29,674,016 | 0.71% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
NEW | 459,314 | $29,368,537 | 0.70% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 119,102 | $29,113,292 | 0.69% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Held | 5,157,290 | $28,571,386 | 0.68% | |
| CI |
Cigna Group
Healthcare
|
Reduced | 98,263 | $26,211,655 | 0.62% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 507,008 | $24,868,742 | 0.59% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Added | 206,591 | $24,850,831 | 0.59% | |
| ALGN |
Align Technology Inc
Healthcare
|
Reduced | 139,680 | $23,945,342 | 0.57% | |
| STE |
STERIS plc
Healthcare
|
Reduced | 99,878 | $22,086,022 | 0.53% | |
| GMED |
Globus Medical Inc
Healthcare
|
Reduced | 247,261 | $21,304,007 | 0.51% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
NEW | 1,250,000 | $20,562,500 | 0.49% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Reduced | 93,567 | $20,349,886 | 0.48% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.